CardioCommand, Inc. is a medical device company specializing in temporary cardiac monitoring and pacing through innovative technology integrated with electrode catheters in the human esophagus. Their premier product lines include transesophageal atrial pacing (TAP) systems used in cardiology electrophysiology testing, cardiology stress testing, and anesthesia/surgery markets. The company's products offer key benefits such as better heart rate control, increased accuracy in cardiac stress testing, fewer side effects, faster stress levels, safety, cost-effectiveness, ease of use, and portability. Additionally, CardioCommand provides contract manufacturing services and has been serving clinicians with innovative medical devices since 1994.